Renal transplantation: Can we reduce calcineurin inhibitor/stop steroids? Evidence based on protocol biopsy findings

Journal of the American Society of Nephrology

Volumn 14, Issue 3, 2003, Pages 755-766

  Gotti, Eliana ^a   Perico, Norberto ^a,b   Perna, Annalisa ^a   Gaspari, Flavio ^a   Cattaneo, Dario ^a   Caruso, Raffaele ^a   Ferrari, Silvia ^a   Stucchi, Nadia ^a   Marchetti, Gianfranco ^a   Abbate, Mauro ^a   Remuzzi, Giuseppe ^a  

^a OSPEDALI RIUNITI   (Italy)

^b MARIO NEGRI INST PHARMACOL RES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; IOHEXOL; METHYLPREDNISOLONE; PREDNISONE;

4 AMINOHIPPURIC ACID CLEARANCE; ACUTE GRAFT REJECTION; ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CHOLELITHIASIS; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG SAFETY; FEMALE; FOLLOW UP; GALLSTONE; GLOMERULUS FILTRATION; HEART INFARCTION; HISTOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY DYSFUNCTION; KIDNEY TRANSPLANTATION; MALE; OSTEOPOROSIS; PLASMA CLEARANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TRANSIENT ISCHEMIC ATTACK;

EID: 19244365875     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000048717.97169.29     Document Type: Article

References (42)

1. Perico N, Remuzzi G: Prevention of transplant rejection. Current treatment guidelines and future developments. Drugs 54: 533- 570, 1997
2. Chan L, Gaston RS, Hariharan S: Evolution of immunosuppression and continued importance of acute rejection in renal transplantation. Am J Kid Dis 38[Suppl 6]: S2-S9, 2001
3. Hariharan S: Long-term kidney transplant survival. Am J Kid Dis 38[Suppl 6]: S44-S50, 2001
4. Cohen D, Galbraith C: General health management and long- term care of the renal transplant recipient. Am J Kid Dis 38[Suppl 6]: S10-S24, 2001
5. Gaston RS: Maintenance immunosuppression in the renal transplant recipient: an overview. Am J Kid Dis 38[Suppl 6]: S25-S35, 2001
6. Kasiske BL, Chakkera HA, Louis TA, Ma JZ: A meta-analysis of immunosuppression withdrawal trials in renal transplantation. J Am Soc Nephrol 11: 1910, 1917, 2000
7. Remuzzi G, Perico N: Cyclosporine-induced renal dysfunction in experimental animals and humans. Kidney Int 48[Suppl 52]: S70-S74, 1995
8. Weir MR, Traver Ward M, Blahut SA, Klassen DK, Cangro CB, Bartlett ST, Fink JC: Long-term impact of discontinued or reduced calcineurin inhibitor in patients with chronic allograft nephropathy. Kidney Int 59: 1567-1573, 2001
9. Bennett WM, De Mattos A, Meyer MM, Andoh T, Barry JM: Chronic cyclosporine nephropathy: The Achilles' heel of immunosuppressive therapy. Kidney Int 50: 1089-1100, 1996
10. Pascual M, Theruvath T, Kawai T, Tolkoff-Rubin N, Cosimi B: Strategies to improve long-term outcomes after renal transplantation. N Eng J Med 346: 580-590, 2002
11. Gaspari F, Perico N, Ruggenenti P, Mosconi L, Amuchastegui CS, Guerini E, Daina E, Remuzzi G: Plasma clearance of nonradioactive iohexol as a measure of glomerular filtration rate. J Am Soc Nephrol 6: 257-263, 1995
12. Perico N, Ruggenenti P, Gaspari F, Mosconi L, Benigni A, Amuchastegui CS, Gasparini F, Remuzzi G: Daily renal hypoperfusion induced by cyclosporine in patients with renal transplantation. Transplantation 54: 56-60, 1992
13. Solez K, Axelsen RA, Benediktsson H, Budrick JF, Cohen AH, Colvin RB, Croker BP, Droz D, Dunnill MS, Halloran PF, Hayry PJ, Jennette JC, Keown PA, Marcussen N, Mihatsch MJ, Morozumi MJ, Myers BD, Nast CC, Olsen S, Rosen S, Sachs DH, Salomon DR, Sanfilippo F, Verani R, Von Willebrand E, Yamaguchi Y: International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology. Kidney Int 44: 411-422, 1993
14. Mihatsch MJ, Ryffel B, Gudat F, Thiel G: Cyclosporine toxicity. In: Renal Pathology: With Clinical and Functional Correlations, edited by Tisher CC, Brenner BM, Philadelphia, JB Lippincott Company, 1994, pp 1641-1681
15. Croker BP, Ramos EL: Pathology of the renal allograft. In: Renal Pathology: With Clinical and Functional Correlations, edited by Tisher CC, Brenner BM, Philadelphia: JB Lippincott Company, 1994, pp 1590-1640
16. Racusen LC, Solez K, Colvin RB, Bonsib SM, Castro MC, Croker BP, Cavallo T, Demetris J, Drachenberg CB, Fogo AB, Furness P, Gaber LW, Gibson IW, Glotz D, Goldberg JC, Grande J, Halloran PF, Hansen HE, Hartley B, Hayry PJ, Hill CM, Hoffman EO, Hunsicker LG, Lindblad AS, Marcussen N, Mihatsch MJ, Nasady T, Nickerson P, Olsen TS, Papadimitriou JC, Randhawa PS, Rayner DC, Roberts I, Rose S, Rush D, Salinas-Madrigal L, Salomon DR, Sund S, Taskinen E, Trpkov K, Yamaguchi Y: The Banff 97 working classification of renal allograft pathology. Kidney Int 55: 713-723, 1999
17. Bröchner-Mortensen J: A simple method for the determination of glomerular filtration rate. Scand J Clin Lab Invest 30: 271-274, 1972
18. Smith HW, Finkelstein N, Aliminosa L, Crawford B: The renal clearance of substituted hippuric acid derivatives and other aromatic acid in dog and man. J Clin Invest 24: 388-404, 1945
19. Gaspari F, Anedda MF, Signorini O, Remuzzi G, Perico N: Prediction of cyclosporine area under the curve using a three-point sampling strategy after Neoral administration. J Am Soc Nephrol 8: 647-652, 1997
20. Hand DJ, Taylor CC: Multivariate Analysis of Variance and Repeated Measures. London, Chapman & Hall, 1997
21. Gaspari F, Perico N, Matalone M, Signorini O, Azzollini N, Mister M, Remuzzi G: Precision of plasma clearance of iohexol for estimation of GFR in patients with renal disease. J Am Soc Nephrol 9: 310-313, 1998
22. Kupin W, Venkat KK, Oh HK, Dienst S: Complete replacement of methylprednisone by azathioprine in cyclosporine-treated primary cadaveric renal transplant recipients. Transplantation 15: 53-55, 1988
23. Hricik DE, Lautman J, Bartucci MR, Moir EJ, Mayes JT, Schulak JA: Variable effects of steroid withdrawal on blood pressure reduction in cyclosporine-treated renal transplant recipients. Transplantation 53: 1232-1235, 1992
24. Ratcliffe PJ, Dudley CR, Higgins RM, Firth JD, Smith B, Morris PJ: Randomized control trial of steroid withdrawal in renal transplant recipients receiving triple immunosuppression. Lancet 348: 643-648, 1996
25. Hollander AA, Hené RJ, Hermans J, Van Es LA, Van Der Woude FJ: Late prednisone withdrawal in cyclosporine-treated kidney transplant patients: A randomized study. J Am Soc Nephrol 8: 294-301, 1997
26. Ahsan N, Hricik DE, Matas A, Rose S, Tomlanovich S, Wilkinson A, Ewell M, MacIntosh M, Stablein D, Hodge E: Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil - A prospective randomized study. Steroid Withdrawal Study Group. Transplantation 68: 1865-1874, 1999
27. Sivaraman P, Nussbaumer G, Landsberg D: Lack of long-term benefits of steroid withdrawal in renal transplant recipients. Am J Kid Dis 37: 1162-1169, 2001
28. Sinclair NR, for the Canadian Multicenter Transplant Study Group: Low dose steroid therapy in cyclosporine-treated renal transplant recipients with well functioning grafts. Can Med Assoc J 147: 645-659, 1992
29. Canafax DM, Sutherland DER, Anscher NL: Cyclosporin nephrotoxicity in renal allograft recipients: Conversion to azathioprine to improve renal function. Transplant Proc 15[Suppl 1]: 2874, 1983
30. Jacobson JE, Pontin A, Van Zyl-Smit R, Pascoe M, Cassidy MJD, Swanepoel CR: Results of conversion immunosuppression in 193 cadaver and 42 living-related donor renal allografts. Transplant Proc 20: 155-156, 1988
31. Kasiske BL, Heim-Duthoy K, Ma JZ: Elective cyclosporine withdrawal after renal transplantation. A meta-analysis. JAMA 269: 395-400, 1993
32. Heim-Duthoy K, Chitwood KK, Tortorice KL, Massy ZA, Kasiske BL: Elective cyclosporine withdrawal 1 year after renal transplantation. Am J Kid Dis 24: 846-853, 1994
33. Mourad G, Vela C, Ribstein J, Mimran A: Long-term improvement in renal function after cyclosporine reduction in renal transplant recipients with histologically proven chronic cyclosporine nephropathy. Transplantation 65: 661-667, 1998
34. Nankivell BJ, Fenton-Lee CA, Kuypers DRJ, Cheung E, Allen RDM, O'Connell PJ, Chapman JR: Effect of histological damage on long-term kidney transplant outcome. Transplantation 71: 515-523, 2001
35. Myers B, Newton L: Cyclosporine-induced chronic renal nephropathy: An obliterative microvascular toxicity. J Am Soc Nephrol 2: S45-S52, 1991
36. Almond PS, Matas A, Gillingham K, Dunn DL, Payne WD, Gores P, Gruessner R, Najarian JS: Risk factors for chronic rejection in renal allograft recipients. Transplantation 55: 752-756, 1993
37. Matas A, Gillingham K, Sutherland D: Half-life and risk factors for kidney transplant outcome - Importance of death with function. Transplantation 55: 757-761, 1993
38. Lorber MI, Flechner SM, Van Buren CT, Kerman RH, Kahan BD: Cyclosporine, azathioprine, and prednisone as treatment for cyclosporine-induced nephrotoxicity in renal transplant recipients. Transplant Proc 17[Suppl 1]:285, 1985
39. Rocher LL, Hodgson RJ, Merion RM, Swartz RD, Keavey S, Turcotte JC, Campbell DA Jr: Amelioration of chronic renal allograft dysfunction in cyclosporine-treated patients by addition of azathioprine. Transplantation 47: 249-254, 1989
40. Myers BD, Newton L, Boshkos C: Chronic injury of human renal microvessels with low-dose cyclosporine therapy. Transplantation 46: 694-703, 1988
41. Versluis DJ, Ten Kate FJ, Wenting GJ, Jeekel J, Weimar W: Histological lesions associated with cyclosporin: Incidence and reversibility in one year old kidney transplants. J Clin Pathol 41: 498-503, 1988
42. Morozumi K, Thiel G, Albert FW, Banfi G, Gudat F, Mihatsch MJ: Studies on morphological outcome of cyclosporine-associated arteriolopathy after discontinuation of cyclosporine in renal allografts. Clin Nephrol 38: 1-8, 1992